Relay Therapeutics (RLAY) Treasury Shares (2019 - 2025)

Relay Therapeutics (RLAY) has 7 years of Treasury Shares data on file, last reported at $2.4 million in Q4 2025.

• Treasury Shares for Q4 2025 came in at $2.4 million, down 58.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.4 million (down 58.39% YoY), and the FY2025 annual result was $2.4 million, down 58.39% from the prior year.
• Treasury Shares fell to $2.4 million in Q4 2025 per RLAY's latest filing, from $5.8 million in the prior quarter.
• Over five years, Treasury Shares peaked at $5.8 million in Q4 2024 and troughed at $691205.0 in Q4 2021.
• A 5-year average of $2.7 million and a median of $2.4 million in 2025 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2021 and 2025: Treasury Shares soared 718.1% in 2021, then plunged 58.39% in 2025.
• A 5-year view of Treasury Shares shows it stood at $691205.0 in 2021, then jumped by 126.67% to $1.6 million in 2022, then soared by 90.98% to $3.0 million in 2023, then jumped by 94.12% to $5.8 million in 2024, then sank by 58.39% to $2.4 million in 2025.
• Business Quant data shows RLAY's Treasury Shares at $2.4 million in Q4 2025, $5.8 million in Q4 2024, and $3.0 million in Q4 2023.